Podcast 9 Aug 2024
Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA
This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.
CRISPR
- Latest Posts
In Depth 8 Jul 2024
Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
In Depth 27 Jun 2024
CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?
Discover more about CRISPR-Cas13, including how it differs from CRISPR-Cas9 and what the technology can be used for.
Best in Biotech 20 Jun 2024
CRISPR technology’s next wave: Eight companies to watch in 2024
Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies.
In Depth 6 Jun 2024
CRISPR: A promising path to treating blindness
Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness.
In Depth 23 May 2024
Is prime editing ready for prime time?
Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
ADVERTISEMENT
ADVERTISEMENT
Podcast 5 Apr 2024
Colossal Biosciences’ 2028 goal: Bringing back the woolly mammoth
Discover the pioneering work of Colossal Biosciences, a biotech firm leading the charge in de-extinction and endangered species preservation.
In Depth 4 Apr 2024
Seven diseases CRISPR technology could cure
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
Podcast 1 Mar 2024
The final chapter in genomic medicines?
Explore the future of genomic medicine with Tome Biosciences’ programmable genomic integration technique, set to revolutionize gene editing.
Best in Biotech 22 Feb 2024
10 gene therapy companies you should know about
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.
In Depth 12 Feb 2024
RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
In Depth 9 Feb 2024
Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
ADVERTISEMENT
